Biotech Careers

Thank you for your increasing coverage of professional and career-related material of interest to scientists. I've noticed the trend, and it is certainly a positive one for The Scientist. However, I must take exception to the cover story by Franklin Hoke in the March 20, 1995, issue. This feature, entitled "Smaller Biotechs Capturing Top Talent From Large Pharmaceutical Competitors" [page 1], seems to perpetuate a number of stereotypes that could have been presented in a more balanced fashion.

Written byDavid Jensen
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Thank you for your increasing coverage of professional and career-related material of interest to scientists. I've noticed the trend, and it is certainly a positive one for The Scientist.

However, I must take exception to the cover story by Franklin Hoke in the March 20, 1995, issue. This feature, entitled "Smaller Biotechs Capturing Top Talent From Large Pharmaceutical Competitors" [page 1], seems to perpetuate a number of stereotypes that could have been presented in a more balanced fashion. I've always felt that scientists want accurate information about every issue in their life, whether at the bench or when entering the worst job market of the decade.

I would agree that there are many exciting opportunities available with the young biotech companies. Your article, though, seems to indicate that there is some sort of a stampede taking place in which large-company employees are suddenly moving in droves to the startup. This ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies